Skip to content
healthcare.dev

Dapagliflozin

NDC 59651-160, Dapagliflozin, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
59651-160
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211468
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-160 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN10 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
59651-160-305965101603030 TABLET, FILM COATED in 1 BOTTLE (59651-160-30)
59651-160-905965101609090 TABLET, FILM COATED in 1 BOTTLE (59651-160-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f56593f7-588e-489d-9fad-b459e90dab18
  • NADAC price for package 59651016030

    GET /v1/drugs/nadac/59651016030

Use it

Look up 59651-160 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-160 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.